The problem of delusional ugliness: Is it really body dysmorphic disorder?

World Journal of Biological Psychiatry

Volumn 7, Issue 2, 2006, Pages 110-115

  Fontenelle, Leonardo F ^a,c   Mendlowicz, Mauro V ^a,b   Kalaf, Juliana ^a   Versiani, Marcio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c NONE   (Brazil)

Author keywords

Body dysmorphic disorder; Delusional disorder; Psychopathology

Indexed keywords

CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; OLANZAPINE; PIMOZIDE; PLACEBO; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR;

BODY DYSMORPHIC DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESPONSE; HUMAN; MONOTHERAPY; NEUROANATOMY; OBSESSIVE COMPULSIVE DISORDER; REVIEW; SOMATIC DELUSION;

ANTIDEPRESSIVE AGENTS; BODY IMAGE; DELUSIONS; ESTHETICS; HUMANS; SOMATOFORM DISORDERS;

EID: 33646693830     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970500287420     Document Type: Review

References (51)

1. Albertini, RS and Phillips, KA. (1999) Thirty-three cases of body dysmorphic disorder in children and adolescents J Am Acad Child Adolesc Psychiatry, 38, pp. 453-459.
2. American Psychiatric Association.(2000) Diagnostic and statistical manual of mental disorders 4th ed. Text revision. Washington DC: American Psychiatric Press.
3. Appelbaum, PS and Robbins, PC and Roth, LH. (1999) Dimensional approach to delusions: Comparison across types and diagnoses Am J Psychiatry, 156, pp. 1938-1943.
4. Appelbaum, PS and Robbins, PC and Vesselinov, R. (2004) Persistence and stability of delusions over time Compr Psychiatry, 45, pp. 317-324.
5. Baker, PB and Cook, BL and Winokur, G. (1995) Delusional infestation. The interface of delusions and hallucinations Psychiatr Clin North Am, 18, pp. 345-361.
6. Berrios, GE and Luque, R. (1995) Cotard's syndrome: Analysis of 100 cases Acta Psychiatr Scand, 91, pp. 185-188.
7. Bystritsky, A and Ackerman, DL and Rosen, RM and Vapnik, T and Gorbis, E and Maidment, KM and et al. (2004) Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: A placebo-controlled trial J Clin Psychiatry, 65, pp. 565-568.
8. Carey, P and Seedat, S and Warwick, J and van Heerden, B and Stein, DJ. (2004) SPECT imaging of body dysmorphic disorder J Neuropsychiatry Clin Neurosci, 16, pp. 357-359.
9. Cutting, J.(1997) Principles of psychopathology. Oxford: Oxford University Press.
10. de Leon, J and Bott, A and Simpson, GM. (1989) Dysmorphophobia: Body dysmorphic disorder or delusional disorder, somatic subtype? Compr Psychiatry, 30, pp. 457-472.
11. Denys, D and de Geus, F and van Megen, HJ and Westenberg, HG. (2004) A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors J Clin Psychiatry, 65, pp. 1040-1048.
12. Eisen, JL and Phillips, KA and Baer, L and Beer, DA and Atala, KD and Rasmussen, SA. (1998) The Brown Assessment of Beliefs Scale: Reliability and validity Am J Psychiatry, 155, pp. 102-108.
13. Fontenelle, LF and Mendlowicz, MV and Mussi, TC and Marques, C and Versiani, M. (2002) The man with the purple nostrils: A case of rhinotrichotillomania secondary to body dysmorphic disorder Acta Psychiatr Scand, 106, pp. 464-466.
14. Garety, PA and Hemsley, DR. (1987) Characteristics of delusional experience Eur Arch Psychiatry Neurol Sci, 236, pp. 294-298.
15. Grant, JE. (2001) Successful treatment of nondelusional body dysmorphic disorder with olanzapine: A case report J Clin Psychiatry, 62, pp. 297-298.
16. Hamann, K and Avnstorp, C. (1982) Delusions of infestation treated by pimozide: A double-blind crossover clinical study Acta Dermatol Venereol, 62, pp. 55-58.
17. Hayashi, H and Oshino, S and Ishikawa, J and Kawakatsu, S and Otani, K. (2004) Paroxetine treatment of delusional disorder, somatic type Hum Psychopharmacol, 19, pp. 351-352.
18. Hollander, E and Allen, A and Kwon, J and Aronowitz, B and Schmeidler, J and Wong, C and et al. (1999) Clomipramine vs desipramine crossover trial in body dysmorphic disorder: Selective efficacy of a serotonin reuptake inhibitor in imagined ugliness Arch Gen Psychiatry, 56, pp. 1033-1039.
19. Insel, TR and Akiskal, HS. (1986) Obsessive-compulsive disorder with psychotic features: A phenomenologic analysis Am J Psychiatry, 143, pp. 1527-1533.
20. Jaspers, K.(1963) General Psychopathology. Manchester: Manchester University Press.
21. Kendler, KS and Glazer, WM and Morgenstern, H. (1983) Dimensions of delusional experience Am J Psychiatry, 140, pp. 466-469.
22. Marbach, JJ. (1978) Phantom bite syndrome Am J Psychiatry, 135, pp. 476-479.
23. McDougle, CJ and Goodman, WK and Leckman, JF and Lee, NC and Heninger, GR and Price, LH. (1994) Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics Arch Gen Psychiatry, 51, pp. 302-308.
24. McDougle, CJ and Epperson, CN and Pelton, GH and Wasylink, S and Price, LH. (2000) A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder Arch Gen Psychiatry, 57, pp. 794-801.
25. McElroy, SL and Phillips, KA and Keck, PE, Jr and Hudson, JI and Pope, HG, Jr. (1993) Body dysmorphic disorder: Does it have a psychotic subtype? J Clin Psychiatry, 54, pp. 389-395.
26. Modell, S and Kurtz, G and Hoff, P. (1996) Dysmorphophobia: Differential-diagnostic aspects Psychopathology, 29, pp. 126-130.
27. Munro, A.(1999) Delusional disorder: Paranoia and related illnesses. Cambridge: Cambridge University Press.
28. Munro, A and Mok, H. (1995) An overview of treatment in paranoia/ delusional disorder Can J Psychiatry, 40, pp. 616-622.
29. Mullen, R. (2003) Delusions: The continuum versus category debate Aust NZ J Psychiatry, 37, pp. 505-511.
30. Opjordsmoen, S. (1993) The duration criteria of delusional disorder in modern classification Psychopathology, 26, pp. 85-89.
31. O'Sullivan, RL and Phillips, KA and Keuthen, NJ and Wilhelm, S. (1999) Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine Psychosomatics, 40, pp. 79-81.
32. Ota, M and Mizukami, K and Katano, T and Sato, S and Takeda, T and Asada, T. (2003) A case of delusional disorder, somatic type with remarkable improvement of clinical symptoms and single photon emission computed tomograpy findings following modified electroconvulsive therapy Prog Neuropsychopharmacol Biol Psychiatry, 27, pp. 881-884.
33. Oulis, P and Mamounas, J and Hatzimanolis, J and Christodoulou, GN. (2000) Clinical dimensions of delusional beliefs: A factor-analytic study Psychopathology., 33, pp. 81-85.
34. Phillips, KA. (1991) Body dysmorphic disorder: The distress of imagined ugliness Am J Psychiatry, 148, pp. 1138-1149.
35. Phillips, KA. (2004) Psychosis in body dysmorphic disorder J Psychiatr Res, 38, pp. 63-72.
36. Phillips, KA. (2005) Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder Am J Psychiatry, 162, pp. 377-379.
37. Phillips, KA and Taub, SL. (1995) Skin picking as a symptom of body dysmorphic disorder Psychopharmacol Bull, 31, pp. 279-288.
38. Phillips, KA and McElroy, SL and Keck, PE, Jr and Pope, HG, Jr and Hudson, JI. (1993) Body dysmorphic disorder: 30 cases of imagined ugliness Am J Psychiatry, 150, pp. 302-308.
39. Phillips, KA and McElroy, SL and Keck, PE, Jr and Hudson, JI and Pope, HG, Jr. (1994) A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases Psychopharmacol Bull, 30, pp. 179-186.
40. Phillips, KA and Albertini, RS and Siniscalchi, JM and Khan, A and Robinson, M. (2001) Effectiveness of pharmacotherapy for body dysmorphic disorder: A chart-review study J Clin Psychiatry, 62, pp. 721-727.
41. Phillips, KA and Albertini, RS and Rasmussen, SA. (2002) A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder Arch Gen Psychiatry, 59, pp. 381-388.
42. Phillips, KA and Price, LH and Greenberg, BD and Rasmussen, SA.(2003) Should the DSM diagnostic grouping be changed?. In Advancing DSM: Dilemmas in psychiatric diagnosis. (pp. 57-83). Washington DC: American Psychiatric Press.
43. Pryse-Phillips, W. (1971) An olfactory reference syndrome Acta Psychiatr Scand, 47, pp. 484-509.
44. Riding, J and Munro, A. (1975) Pimozide in the treatment of monosymptomatic hypochondriacal psychosis Acta Psychiatr Scand, 52, pp. 23-30.
45. Sondheimer, A. (1988) Clomipramine treatment of delusional disorder-somatic type J Am Acad Child Adolesc Psychiatry, 27, pp. 188-192.
46. Stein, DJ and Le Roux, L and Bouwer, C and Van Heerden, B. (1998) Is olfactory reference syndrome an obsessive-compulsive spectrum disorder? Two cases and a discussion J Neuropsychiatry Clin Neurosci, 10, pp. 96-99.
47. Swerdlow NR. Blurry Spectrum Disorders. 2000. In:MAj M, Sartorius N, Okasha A, Zohar J, editors.Obsessive-Compulsive Disorder. Chichester: John Wiley & Sons Ltd. pp 235-238.
48. Torres, AR and Tiosso, AM and Gambarini-Zen, AM. (1996) [Um caso de delírio de infestação parasitária tratado com clomipramina] Revista ABP-APAL, 18, pp. 29-34.
49. Ungvari, G and Vladar, K. (1986) Pimozide treatment for delusion of infestation Act Nerv Super (Praha), 28, pp. 103-107.
50. Wada, T and Kawakatsu, S and Komatani, A and Okuyama, N and Otani, K. (1999) Possible association between delusional disorder, somatic type and reduced regional cerebral blood flow Prog Neuropsychopharmacol Biol Psychiatry, 23, pp. 353-357.
51. Wurtz, R. (1998) Psychiatric diseases presenting as infectious diseases Clin Infect Dis, 26, pp. 924-932.